Peptides vs. Proteins vs. Small Molecules: Key Differences

A comparison of the three major classes of therapeutic molecules — how they differ in size, manufacturing, delivery, regulation, and clinical use.

Filed under basics, written for beginner, patient-consumer, researcher, investor.

Not medically reviewed. Last updated 2026-04-05. Nothing here is medical advice.

Understanding the differences between peptides, proteins, and small molecules is foundational for navigating the pharmaceutical landscape.

Size Comparison

| Property | Small Molecules | Peptides | Proteins |

|----------|----------------|----------|----------|

| Molecular weight | <500 Da | 500-5,000 Da | >5,000 Da |

| Amino acids | N/A | 2-50 | 50+ |

| Examples | Aspirin, metformin | Semaglutide, oxytocin | Antibodies, insulin |

Manufacturing

Small Molecules

• Chemical synthesis (organic chemistry)
• Well-established processes
• Relatively inexpensive at scale
• Defined by chemical structure

Peptides

• Solid-phase peptide synthesis (SPPS) or recombinant production
• Intermediate complexity and cost
• Defined by amino acid sequence and modifications
• Growing manufacturing capacity

Proteins

• Recombinant DNA technology (cell culture)
• Complex manufacturing (mammalian cells, purification)
• Expensive
• Defined by structure, folding, and post-translational modifications

Drug Delivery

Small Molecules

• Usually orally bioavailable
• Cross cell membranes easily
• Broad tissue distribution

Peptides

• Usually injectable (subcutaneous, IV)
• Limited oral bioavailability (oral semaglutide is an exception)
• Can be modified for improved half-life

Proteins

• Injectable (IV, subcutaneous)
• No oral bioavailability
• Long half-life (antibodies: weeks)

Regulatory Classification

• Small molecules: NDA (New Drug Application)
• Peptides: NDA or BLA (depends on size and manufacturing method)
• Proteins: BLA (Biologics License Application)

This comparison is for educational purposes.

More guides: All guides, Safety centre, Peptide library.